PharmaPrimes Laboratories

Pharme_Primes_Logo
Menu
Company Profile

News

The Bioanalysis team at PharmaPrimes has successfully developed and validated bioanalytical methods for quantifying both Semaglutide and Liraglutide in human plasma

The Bioanalysis team at PharmaPrimes has successfully developed and validated a bioanalytical method for quantifying Semaglutide in human plasma

PharmaPrimes is participating for the first time as an official exhibitor at Arab Pharma Expo 2025, held in Amman, Jordan

Pharmaprimes Develops a Method for Bioassay of Indacaterol in Human Serum

PharmaPrimes Signs Strategic Collaboration Agreement with Global Pharma to Strengthen Local Pharmaceutical Manufacturing in the UAE

Milestone Achieved: PharmaPrimes Laboratories has been awarded GLP/GCP accreditation by the JFDA

PharmaPrimes is proud to introduce the latest breakthrough. As the first and only provider of Virtual Bioequivalence service in the region, we are honored to support and elevate the entire pharmaceutical industry

Ready to support your studies with top-notch LC-MS/MS capabilities

PharmaPrimes Laboratories Becomes the First CRO in the Region to Implement a Fully Electronic Quality Management System "ZenQMS"

We have successfully established our QMS with the guidance of Headway Quality Evolution Consultancy

PharmaPrimes is excited to announce our participation in CPHI Middle East, showcasing our advanced pharmaceutical research and development services

JFDA joins ICH in recognition of Jordan's drug achievements